Skip to main content

Table 1 Clinical characteristics of patients with pulmonary tuberculosis

From: Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10

 

HC (n = 20)

AFB-positive TB patients (n = 20)

Age (years)

45 ± 21.9 (22–76)

55 ± 19.8 (18–86)

Sex (m/f)

12/8

13/7

Radiographic features

Infiltration

20/20 (100)

Cavitation

7/20(35)

Effusion

3/20 (15)

Smear grading

4+

5/20 (25)

3+

6/20 (30)

2+

5/20 (25)

1+

4/20 (20)

Resistance

Treatment

HREZa 20/20 (100)

  1. aHERZ, isoniazid, ethambutol, rifampicin, plus pyrazinamide. Categorical variable data are presented as positive/tested (%). Continuous variable data are shown as mean ± SD (range)